SGLT-2 Inhibitors—a Culprit of Diabetic Ketoacidosis Postbariatric Surgery
Sodium-glucose cotransporter-2 SGLT2 inhibitors are antihyperglycemic drugs that are currently being recommended as second-line therapy for patients with diabetes mellitus. They have grown increasingly popular over recent years, as they have been shown to have some protective effects on the heart an...
Saved in:
Main Authors: | Qasim Zafar Iqbal, Danil Mishiyev, Muhammad Raphay Niazi, Zeeshan Zia, Saud Bin Abdul Sattar, Abdullah Jahanghir, Shahed Quyyumi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Case Reports in Critical Care |
Online Access: | http://dx.doi.org/10.1155/2020/8817829 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acute Pancreatitis as an Unusual Culprit of Diabetic Ketoacidosis in a Nondiabetic: A Case-Based Review
by: Steven Imburgio, et al.
Published: (2023-01-01) -
The Role of SGLT2 Inhibitor on the Treatment of Diabetic Retinopathy
by: Wenjun Sha, et al.
Published: (2020-01-01) -
Research Progress of SGLT2 Inhibitors in Cancer Treatment
by: Miao X, et al.
Published: (2025-01-01) -
Fibroelastoma as a Culprit of Syncope
by: Giuliano De Portu, et al.
Published: (2013-01-01) -
The SGLT-2 Inhibitors and their Role in the Treatment of Heart Failure - A Review of Literature
by: Silvia Ciraolo, et al.
Published: (2025-02-01)